期刊文献+

肾上腺髓质素在糖尿病肾病中的变化及作用 被引量:3

The role of adrenomedullin in diabetic nephropathy
下载PDF
导出
摘要 目的 :探讨肾上腺髓质素 (AM)在糖尿病肾病中的变化及作用。方法 :通过体外人肾小球系膜细胞培养实验 ,观察高糖条件对系膜细胞AMmRNA、转化生长因子 - β1(TGF - β1)mRNA表达、分泌及细胞外基质 (层粘连蛋白和Ⅳ型胶原 )含量的影响及肾上腺髓质素干预对高糖不良作用的影响。结果 :在高糖条件下培养的人肾小球系膜细胞AMmRNA、TGF - β1mRNA表达和AM、TGF - β1分泌较低糖对照组分别增加 1 0 1倍、0 5 9倍和 3 4 9倍、1 6 1倍 ;细胞外基质蛋白LN和Ⅳ型胶原含量分别升高 0 95倍和 1 13倍。用不同浓度AM(10 -7、10 -8和 10 -9mol/L)干预后 ,TGF - β1mRNA表达分别下降 5 0 %、2 8%和 16 2 % ,TGF - β1含量分别下降 39%、2 6 %和 11% ;LN含量分别下降 5 3%、4 5 %和 18% ,Ⅳ型胶原含量分别下降 2 9%、2 6 %和 2 0 %。结论 :葡萄糖水平升高是AM表达分泌的剌激因子之一。AM的肾脏保护作用可能与抑制TGF - β1的表达与分泌 ,进而减少基质蛋白和胶原的过度积聚相关。 AIM: To investigate the role of adrenomedullin (AM) in diabetic nephropathy. METHODS: We observed the changes in the expression and secretion of AM, TGF-β 1 in the cultured human mesangial cells under high glucose condition and the contents of the laminin and type IV collagen in the supernatants. The effect of intervention with AM was also observed. RESULTS: High glucose condition resulted in increase in the expression and secretion of AM TGF-β 1 laminin and type IV collagen. AM reversed the influence of high glucose on the cultured human mesangial cells. CONCLUSION: These results showed that high glucose condition is one of stimulating factors of AM and the renal protective action of AM may be associated with suppression of TGF-β 1 and reducing excessive accumulation of laminin and type IV collagen.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2004年第4期643-646,共4页 Chinese Journal of Pathophysiology
基金 江苏省教育厅自然科学基金资助项目 (No .0 0KJD32 0 0 17)
关键词 肾上腺髓质素 糖尿病肾病 转化生长因子Β 细胞外基质 Adrenomedullin Diabetic nephropathies Transforming growth factor beta Extracellular matrix
  • 相关文献

参考文献11

二级参考文献15

共引文献19

同被引文献14

  • 1高峰,刘青娟,段惠军,曹延萍,史永红,王丽晖.氯沙坦降低糖尿病大鼠肾脏肾上腺髓质素和内皮素的表达[J].基础医学与临床,2007,27(3):271-274. 被引量:3
  • 2Rodriguez de Cordoba S, Esparza-Gordillo J, Goicoechea de Jorge E, et al. The human complement factor H: functional roles, genetic variations and disease associations. Mol Immunol, 2004,41:355-367.
  • 3Zudaire E, Cuttitta F, Martynez A. Regulation of pancreatic physiology by adrenomedullin and its binding protein. Regulatory Peptides, 2003, 112:121-130.
  • 4Nicholas SB. Advances in pathogenetic mechanisms of diabetic nephropathy. Cell Mol Bio, 2003,49 : 1319-1325.
  • 5Elsasser TH, Pio R, Martinez A, et al. Identification, characterization, and physiological actions of factor H as an adrenomedullin binding protein present in human plasma. Microsc Res Tech, 2002,57:23-27.
  • 6Wu RQ, Zhou M, Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-α in macrophage cell line and rat Kupffer cells. Regulatory Peptides, 2003,112 : 19-26.
  • 7Pio R, Martinez A, Edward JU. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem, 2001,276:12292-12300.
  • 8AUard J, Buldon M, CeUier E. ACE inhibitor reduces growth fac- tor receptor expression and signaling but also albuminuria through B2 - kin in glomerular receptor activation in diabetic rats[ J ]. Am J Physio[ Renal Physiol, 2007, 293(4) : 1 083 - 1 092.
  • 9Jacobsen P, Rossing K, Parring HH. Single versusdualblockade of the re - nin- angiotensin system in diabetic nephropathy [J ]. Curr Opin Nephrol Hypertens, 2004,13(3) : 319 - 342.
  • 10Shimosawa T, Fujita T. AdrenomeduUin and its related peptide[J].En- docr J, 2005,52(1):1 - 10.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部